(Q50114587)

25 February 2018

title

Prescription duration after drug copay changes in older people: methodological aspects. (English)

1 reference

25 February 2018

author

Sebastian Schneeweiss

series ordinal

1

object named as

Sebastian Schneeweiss

1 reference

25 February 2018

Stephen B Soumerai

series ordinal

3

object named as

Stephen B Soumerai

1 reference

25 February 2018

author name string

Malcolm Maclure

series ordinal

2

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

25 February 2018

Journal of the American Geriatrics Society

published in

1 reference

25 February 2018

volume

50

1 reference

25 February 2018

issue

3

1 reference

25 February 2018

page(s)

521-525

1 reference

25 February 2018

The Medicare prescription drug benefit: how will the game be played?

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

Adverse events associated with prescription drug cost-sharing among poor and elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

Medicare beneficiaries' management of capped prescription benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50120.X

10.1046/J.1532-5415.2002.50120.X

21 January 2018

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018